Clinical trial
STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery: A Randomized Controlled, Non-inferiority Trial
NCT04491617 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery: A Randomized Controlled, Non-inferiority Trial
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 27, 2020
- Completion date
- August 31, 2022
- Enrollment
- 129 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
incontinence, opioid use, postoperative pain, prolapse; female